Press Releases

Date Title and Summary
Toggle Summary Accuray Incorporated to Report Financial Results for Third Quarter Fiscal Year 2009
SUNNYVALE, Calif ., April 13 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its third quarter fiscal year 2009, ending March 28, 2009 on Tuesday, May 5, 2009 after the market closes.
Toggle Summary Second European Radiosurgery Workshop Yields Record Attendance
--Attendance Doubles with More Than 200 Health Professionals From 28 Countries Participating SUNNYVALE, Calif., April 10, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the second European
Toggle Summary First Patients Treated in India Using CyberKnife Radiosurgery
Newly Installed System at Apollo Hospital Treats Six and Preps Eight Patients in First Week SUNNYVALE, Calif ., April 3 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the first patients in India have been treated
Toggle Summary Stanford Study on CyberKnife Radiosurgery for Prostate Cancer Demonstrates 100 Percent PSA Response at 33 months
Prior Studies Demonstrate Frequency of Prostate Motion, Supporting Need for the CyberKnife System's Real-Time Tracking to Spare Surrounding Sensitive Structures SUNNYVALE, Calif ., March 31 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery,
Toggle Summary Japan Treats First Extracranial Patients Using CyberKnife Radiosurgery
First Patients Treated in Yokohama, Japan Following Expanded Japanese Regulatory Approval SUNNYVALE, Calif ., March 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the first extracranial patients were treated in
Toggle Summary CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth
SUNNYVALE, Calif ., March 2 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today significant growth in CyberKnife lung cancer treatments in calendar year 2008. The number of lung cancer patients treated with CyberKnife
Toggle Summary Clinical Evidence Grows in Support of CyberKnife Treatment for Intracranial and Extracranial Tumors
CyberKnife Users' Meeting Highlights Clinical Studies and Emerging Trends in Brain, Lung and Prostate Radiosurgery SUNNYVALE, Calif ., Feb. 26 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced highlights from the clinical
Toggle Summary 10 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service
--New Service Helps Customers to Treat More Patients Without Added Fixed Costs SUNNYVALE, Calif., Feb 20, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that 10 percent of its U.S.
Toggle Summary Neurosurgery Journal Issues Supplement Dedicated to CyberKnife Radiosurgery Experience
Supplement Features 15 Peer Reviewed Papers Describing CyberKnife Radiosurgery for Brain and Spine Applications SUNNYVALE, Calif ., Jan. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Neurosurgery, the official
Toggle Summary Accuray Announces Results for Second Quarter of Fiscal 2009
SUNNYVALE, Calif ., Jan. 29 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the second quarter of fiscal 2009, ended December 27, 2008 . For the second quarter of fiscal 2009, Accuray reported total

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.